
Marco Barbanti
Latest contributions
Redo TAVI - How to treat different TAVI platforms when they fail
22 May 2025 – From EuroPCR 2025
Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

How to handle the most clinically relevant challenges in TAVI
21 May 2025 – From EuroPCR 2025
This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...

How to manage coronary artery disease in TAVI candidates?
20 May 2025 – From EuroPCR 2025
Understand the comprehensive management of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI). This session reviews evidence-based evaluation, decision-making, and treatment strategies for significant coronary lesions, including severe left main and multivessel disease, illustrated through detailed case studies.

How to manage coronary artery disease in TAVI candidates?
20 May 2025 – From EuroPCR 2025
Martine Gilard, Antonio Mangieri, and Marco Barbanti explore the strategy for handling coronary artery disease in patients undergoing TAVI. Is coronary angiography always required beforehand? Should PCI be performed in all cases—and if so, when? This exchange offers key insights to help guide your decisions on...

PCI of bifurcation lesions: management of complications - Part 1
16 May 2024 – From EuroPCR 2024
Explore strategies for managing complex PCI of bifurcation lesions through case discussions. From stent deformation and delicate diagonal wiring to wire fracture with snare failure, decoiled coronary guidewires, misplaced stents, spontaneous coronary artery dissection, and late tamponade after PCI, this session covers how to effectively respond...

New data on TAVI
16 May 2024 – From EuroPCR 2024
This session presents the latest research and data on transcatheter aortic valve implantation (TAVI). It covers a range of topics, including long-term results of TAVI versus surgical aortic valve replacement in low-risk severe aortic stenosis, real-world experience with novel transcatheter heart valve devices, outcomes in patients...

Challenging situations to access the aortic valve - Part 1
15 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that showcase challenging situations in accessing the aortic valve, including cases with severe peripheral arterial disease, tortuous aortic anatomy, and complex comorbidities. The session provides an opportunity to learn from the experiences of experts in navigating these complex scenarios...

Challenging TAVI cases
19 Nov 2023 – From PCR London Valves 2023
This PCR London Valves 2023 session aims to analyse some of the complex aspects of TAVI by looking at challenging clinical and anatomical scenarios to enable you to learn how to manage potential complications by learning about innovative strategies and exploring different approaches.

TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023

TAVI step by step
19 Nov 2023 – From PCR London Valves 2023
Watch this interactive session to get tips and tricks to solve the technical difficulties that can come up during a TAVI, and learn more about mastering CT imaging for successful TAVI planning, understanding valve selection principles, and refining TAVI procedures for improved efficiency and technique.

Native TAVI in small annulus with low coronary take-off - Lifetime management
27 Jul 2023
Analyze the case of this 78-year-old female patient with diabetes, obesity, HTN and hyperlipidemia, who presented with severe symptomatic AS, severely calcified posterior mitral leaflet, and both mild mitral and tricuspid regurgitations, and tell us how you would treat this woman!

Author

Coronary access and PCI after TAVI
16 May 2023 – From EuroPCR 2023
Watch this session to learn more about the epidemiology of PCI after TAVI, to learn how to approach an elective patient with TAVI requiring PCI, or a patient with THV requiring urgent coronary angiography and PCI, among others.

Optimising immediate and long-term outcomes after TAVI
29 Nov 2022 – From PCR London Valves 2022
This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.

Challenging scenarios: bicuspid aortic valves
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.

Create the future of TAVI - Optimisation of the procedure and patient pathway
27 Nov 2022 – From PCR London Valves 2022
Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...

TAVI: emerging evidence
27 Nov 2022 – From PCR London Valves 2022
Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...

TAVI in complex scenario
18 May 2022 – From EuroPCR 2022
Watch these videos to discover a selection of the most complex and high-risk TAVI cases presented during EuroPCR 2022: augmented reality for procedural planning in complex clinical scenario, mechanical circulatory support during high-risk TAVI in the COVID-19 era, TTE and IVL-assisted zero-contrast transfemoral TAVR, and more!

Coronary artery disease and TAVI
18 May 2022 – From EuroPCR 2022
What are the need and possibilities for access to the coronary arteries after TAVI procedure? How can commissural alignment be achieved to facilitate access to the coronary arteries after TAVI procedure? And how to access coronaries arteries through a stent framework? Find some answers in this EuroPCR...

TAVI in a patient with asymptomatic severe aortic stenosis - Session with LIVE case
17 May 2022 – From EuroPCR 2022
Watch this LIVE demonstration from London, United Kingdom to find out how this asymptomatic, 70-year-old, overweight, previously CABG (205) male patient with permanent atrial fibrillation and unlimited exercise tolerance was treated.

How should I treat? - TAVI in small anatomy with significant LVOT calcification
20 Jan 2022
An 89-year-old man was referred for treatment of severe symptomatic aortic stenosis. This case describes the decision-making in performing TAVI in a patient with twin challenges of small annulus and significant LVOT calcification.

Author

Author

Author

How to improve the effectiveness of hemostasis of large bore arteriotomy using a combined approach of suture- and plug-based closure devices
15 Dec 2021
Vascular complications dramatically impact patients outcome after TAVI. This technique is a helpful illustration of how to combine suture and plug based closure devices in order to manage access site successfully.

Author

Author

Lifetime management of patients with severe aortic stenosis
22 Nov 2021 – From PCR London Valves
Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...

TAVI and coronary artery disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.

Timing and indication for PCI in TAVI patients with coronary disease
18 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Dumonteil, Simon Redwood and Marco Barbanti to learn more about the indications for PCI in TAVI patients with coronary disease, to know more about the latest evidence from the ACTIVATION Trial and the RE-ACCESS Study, and to discover some interesting tips...
